Showing results (431-440 of 484) with videos related to
Sort By:
Pageof 49
Comparative Medicine|February 18, 2010
Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbitsAruna Panda, Ivan Tatarov, Angela R Melton-Celsa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen eraCorey A Carter, Timothy Donahue, Leon Sun, et al.Experimental Cell Research|January 18, 2006
Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell linesYongpeng Gu, Hongzhen Li, Jun Miki, et al.Journal of the American College of Surgeons|February 21, 2009
Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate cancer patientsJeremy D Gates, Mark G Carmichael, Linda C Benavides, et al.International Journal of Cancer|June 17, 1999
Allelic loss on chromosome 6Q in primary prostate cancerV Srikantan, I A Sesterhenn, L Davis, et al.Journal of Clinical Immunology|May 28, 2004
Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patientsMichael M Woll, Christine M Fisher, Gayle B Ryan, et al.Neurology|August 1, 1997
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trialB W van Oosten, M Lai, S Hodgkinson, et al.The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.Genes & Cancer|September 16, 2014
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancerAnshu Rastogi, Shyh-Han Tan, Ahmed A Mohamed, et al.Prostate Cancer and Prostatic Diseases|June 30, 2010
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratificationB Furusato, S-H Tan, D Young, et al.Pageof 49